Larvol Delta - Chiesi-Global-Rare-Diseasesannounced-today-that-the-US-Food-and-Drug-Administration-FDA-has-approved-JUXTAPID-lomitapide-capsules-for-pediatric-use-in-homozygous-familial-hypercholesterolemia-HoFH-for-children-2-years-of-age-and-older

Juxtapid (lomitapide) - Novelion, Chiesi

https://www.globenewswire.com/news-release/2026/03/03/3248283/0/en/Chiesi-Global-Rare-Diseases-Announces-FDA-Approval-of-JUXTAPID-lomitapide-Capsules-for-Pediatric-Use-in-Homozygous-Familial-Hypercholesterolemia-HoFH.html

Mar 3, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next